Video

ACP governmental affairs leaders discuss ACA, Title X


 

REPORTING FROM INTERNAL MEDICINE 2019

American College of Physician leaders in governmental affairs discussed a variety of new health law and policy issues they find concerning in a video interview conducted during the annual meeting of the American College of Physicians.

Vidyard Video

Robert B. Doherty, the ACP’s senior vice president, governmental affairs and public policy, and Shari M. Erickson, the organization’s vice president of governmental affairs and medical practice, addressed the future of the Affordable Care Act (ACA), cuts to the funding of Title X clinics, and the National Rifle Association’s urging of Congress to vote against the Violence Against Women Reauthorization Act.

“We’re very, very concerned by a decision by a Texas judge that, if upheld on appeal, would gut the entire ACA and the decision by the administration not to defend any part of the ACA,” said Mr. Doherty.

Ms. Erikson later discussed a final rule released by the administration that she said “significantly impacts access to care for women,” particularly for those in low-income and underserved areas who may be seen by clinics that receive Title X funding.

She also addressed the rule’s effects on federally qualified health centers and other health clinics near Title X–funded clinics that are forced to close.

On a positive note, Mr. Doherty noted that the ACP is supporting legislation that has been introduced in the House to stabilize the current insurance markets.

Mr. Doherty and Ms. Erikson concluded by discussing an ACP initiative focused on reducing administrative burden for ACP members.

Recommended Reading

Following pelvic floor surgery, patients value functional goals
MDedge ObGyn
Malpractice: More lawsuits does not equal more relocations
MDedge ObGyn
ONC’s Dr. Rucker: Era of provider-controlled data is over
MDedge ObGyn
MedPAC to begin work on Part D redesign
MDedge ObGyn
Proportion of women speaking at medical conferences rises over decade
MDedge ObGyn
As Sanders officially revives Medicare-for-all, Plan B for Democrats gains traction
MDedge ObGyn
Cost gap widens between brand-name, generic drugs
MDedge ObGyn
Direct-to-consumer genetic testing fraught with validity concerns
MDedge ObGyn
‘Heartbeat bills’ give state lawmakers pause on antiabortion tactics
MDedge ObGyn
Survey: Bias against female surgeons persists
MDedge ObGyn